Search results
Jun 19, 2021 · The survey was distributed to the heads of the medical physics departments at 15 cancer centers across Ontario in December of 2018, leveraging an existing and rather unique network of Ontario Health (Cancer Care Ontario) to encourage high participation and response rate.
- Gordon H. Chan, Lee C. L. Chin, Ady Abdellatif, Jean‐Pierre Bissonnette, Lesley Buckley, Daria Comsa...
- 10
- 2021
- 19 June 2021
Jun 19, 2021 · RADIATION ONCOLOGY PHYSICS. Open Access. Survey of patient-specific quality assurance practice for IMRT and VMAT. Gordon H. Chan, Lee C. L. Chin, Ady Abdellatif, Jean-Pierre Bissonnette, Lesley Buckley, Daria Comsa, Dal Granville, Jenna King, Patrick L. Rapley, Aaron Vandermeer. First published: 19 June 2021. https://doi.org/10.1002/acm2.13294.
- Gordon H. Chan, Lee C. L. Chin, Ady Abdellatif, Jean‐Pierre Bissonnette, Lesley Buckley, Daria Comsa...
- 2021
Oct 28, 2020 · Volumetric-modulated arc therapy (VMAT) treatment plans that are highly modulated or complex may result in disagreements between the planned dose distribution and the measured dose distribution. This study investigated established VMAT complexity metrics as a means of predicting phantom-based measurement results for 93 treatments delivered on a ...
- Michael Nguyen, Gordon H. Chan
- 9
- 2020
- 28 October 2020
View Gordon Chan’s profile on LinkedIn, the world’s largest professional community. Gordon has 1 job listed on their profile. See the complete profile on LinkedIn and discover Gordon’s...
- Medical Physicist at Juravinski Cancer Centre
The Cancer Care Ontario (CCO) Physics Community of Practice identified Patient-Specific Quality Assurance (PSQA) as a priority quality initiative. The main objective for the initiative w as to improve the quality and safety in treatment delivery by supporting coordination and standardization of PSQA practice across the province.
- 255KB
- 24
Contact us. The Department of Oncology takes a team approach to its administration. Leading the team is the Chair, with support from the Divisional Directors, Academic Department Manager and administrative support staff.
Our program offers diverse research opportunities in molecular & cellular biology of cancer, clinical & translational oncology, novel therapeutics & diagnostics, and drug & biomarker discovery. This specialization offers both thesis based Master of Science (MSc) and Doctoral (PhD) degrees.
